| Literature DB >> 34763084 |
Zhenguo Yang1, Cheng Huang2, Xueyi Wen2, Wenlin Liu1, Xiaoxiong Huang2, Yufeng Li2, Jiankun Zang2, Zean Weng2, Dan Lu2, Chi Kwan Tsang2, Keshen Li3, Anding Xu4.
Abstract
Blood-brain barrier (BBB) damage can be a result of central nervous system (CNS) diseases and may be a cause of CNS deterioration. However, there are still many unknowns regarding effective and targeted therapies for maintaining BBB integrity during ischemia/reperfusion (I/R) injury. In this study, we demonstrate that the circular RNA of FoxO3 (circ-FoxO3) promotes autophagy via mTORC1 inhibition to attenuate BBB collapse under I/R. Upregulation of circ-FoxO3 and autophagic flux were detected in brain microvessel endothelial cells in patients with hemorrhagic transformation and in mice models with middle cerebral artery occlusion/reperfusion. In vivo and in vitro studies indicated that circ-FoxO3 alleviated BBB damage principally by autophagy activation. Mechanistically, we found that circ-FoxO3 inhibited mTORC1 activity mainly by sequestering mTOR and E2F1, thus promoting autophagy to clear cytotoxic aggregates for improving BBB integrity. These results demonstrate that circ-FoxO3 plays a novel role in protecting against BBB damage, and that circ-FoxO3 may be a promising therapeutic target for neurological disorders associated with BBB damage.Entities:
Keywords: E2F1; autophagy; blood-brain barrier; circular RNA FoxO3; hemorrhagic transfromation; ischemic stroke; mTORC1 complex; proteins aggregates
Mesh:
Substances:
Year: 2021 PMID: 34763084 PMCID: PMC8899525 DOI: 10.1016/j.ymthe.2021.11.004
Source DB: PubMed Journal: Mol Ther ISSN: 1525-0016 Impact factor: 11.454